TCMD compared with PBYI: revenue, margins and what each company keeps, and the suppliers and customers both name

TCMDTactile Systems Technology Inc

Mkt capRevenueRevenue

PBYIPuma Biotechnology, Inc.

Mkt capRevenueRevenue

Compare

TCMDTactile Systems Technology Inc

PBYIPuma Biotechnology, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

TCMD

2 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±14.5%▼−17.12%×1.18

Q1 FY26±16.1%▲+7.22%×0.45

Feb 18 '26±19.1%▲+17.83%×0.93

Q3 FY25±11.7%▲+40.65%×3.47

PBYI

2 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±45.0%▲+9.73%×0.22

May 8 '26±42.0%▲+3.17%×0.08

= impliedTCMD realized, solidPBYI realized, hatchedOne scale, both sides: full bar = 46%× = |realized| ÷ impliedSource: market data

Q1 FY26

±21.7%

▼−25.00%

×1.15

Q3 FY25±18.4%▲+22.24%×1.21

TCMDTactile Systems Technology Inc

23.03▼−5.28%· post 23.03

Mkt cap$521.9MRevenue$86MQ2 FY26Revenue$330MFY25

PBYIPuma Biotechnology, Inc.

10.42▼−1.09%· post 10.43

ClosedOct 30 '26

Mkt cap$538.9MRevenue$57MQ2 FY26Revenue$228MFY25

Compare

ClosedOct 30 '26

TCMDTactile Systems Technology Inc

PBYIPuma Biotechnology, Inc.

23.03▼−5.28%post 23.03

Price

10.42▼−1.09%post 10.43

$521.9M

Mkt cap

$538.9M

Q2 FY26$86M

Revenue

$57MQ2 FY26

FY25$330M

Revenue

$228MFY25

TCMD23.03▼−5.28%vsPBYI10.42▼−1.09%ClosedOct 30 '26